Nivagen Pharmaceuticals
Sacramento
About Nivagen Pharmaceuticals
Nivagen Pharmaceuticals is engaged in the development, acquisition, and sales of generic prescription drugs and over-the-counter products for the North American market. It envisions delivering high-quality products at affordable prices by leveraging global partnerships with the best FDA-approved manufacturing facilities across the world. The US generic prescription market is currently at approximately $60 billion, and over $120 billion's worth of products will be coming off of patent protection in the next 10 years. Nivagen believes that, with its strategic partnership model of global alliances with highly efficient pharmaceutical companies across the globe, it can provide cost savings to the consumer while creating value for all members of the supply chain.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $31.0M
- Funding stage: M&A
- Last round: Series Unknown (Aug 2023)
- Website: nivagen.com
- Phone: +1 916-364-1662
Industries & Categories
Manufacturing, Market Research, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/nivagen-pharmaceuticals-98355 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.